The Carbon Costs of In-Person Versus Virtual Medical Conferences for the Pharmaceutical Industry: Lessons from the Coronavirus Pandemic

BACKGROUND: Many in-person congresses have shifted to a virtual format owing to coronavirus disease 2019 (COVID-19). We assessed carbon emissions savings associated with virtual attendance at international medical congresses for a mid-sized pharmaceutical company, to identify which aspects are drivi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gattrell, William T., Barraux, Aurélie, Comley, Sam, Whaley, Michael, Lander, Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881751/
https://www.ncbi.nlm.nih.gov/pubmed/35218551
http://dx.doi.org/10.1007/s40290-022-00421-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881751/
https://www.ncbi.nlm.nih.gov/pubmed/35218551
http://dx.doi.org/10.1007/s40290-022-00421-3

Ejemplares similares